IRIS

This article reports on the most recent development of Induced pluripotent stam cell technique (IPS), and highlights the limitations for the use as an alternative to traditional experimental models.

Induced Pluripotent Stem Cell Derived Cardiomyocytes and Long QT Syndrome: Is Personalized Medicine Ready for Prime Time?

PRIORI, SILVIA GIULIANA
2011-01-01

Abstract

This article reports on the most recent development of Induced pluripotent stam cell technique (IPS), and highlights the limitations for the use as an alternative to traditional experimental models.
2011
Molecular Biology & Genetics considers all aspects of basic and applied genetics, including molecular genetics, prokaryotic and eukaryotic gene expression, mechanisms of mutagenesis, structure, function and regulation of genetic material. Also included are resources concerned with clinical genetics, patterns of inheritance, genetic cause, and screening and treatment of disease. Resources dealing specifically with developmentally regulated gene expression, or with signal transduction pathways that modulate gene expression at the cellular level are excluded and are covered in the Cell and Developmental Biology category.
CIRCULATION RESEARCH
sì
WOS:000295368300001
2-s2.0-80053494343
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
109
8
822
824
3
Pluripotent Stem Cell; Cardiomyocytes; Long QT Syndrome
1
info:eu-repo/semantics/article
262
Priori, SILVIA GIULIANA
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/375992
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact